Novartis Ag (NVS) Capital Expenditures (2009 - 2026)
Novartis Ag (NVS) reported Capital Expenditures of $321 million for Q2 2026, down 3.0% from $331 million a year earlier.
Powered by 
Analysis
Novartis Ag (NVS) Capital Expenditures (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Novartis Ag's Capital Expenditures came in at -$988 million; for FY2025, it came in at $1.55 billion, up 13.3% from FY2024.
- Capital Expenditures has increased for three consecutive years, with a five-year compound annual growth rate of 4.0% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $1.37 billion in FY2024 (+28.9%), $1.06 billion in FY2023 (+15.7%), $916 million in FY2022 (-14.1%) and $1.07 billion in FY2021 (-16.4%).
- Five-year quarterly Capital Expenditures spans a low of -$609 million in Q4 2025 and a high of $331 million in Q2 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$346 million (Q1 2026), -$609 million (Q4 2025) and -$354 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.17 Bn | 1,237.79 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 660.04 Bn | 579.90 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 521.06 Bn | 494.17 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.60 Bn | 370.60 Bn | - | - |
| 5 | Novartis Ag | 311.97 Bn | 285.20 Bn | - | - |
| 6 | Astrazeneca | 288.69 Bn | 262.37 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 252.29 Bn | 207.69 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 213.47 Bn | 213.47 Bn | - | 237.00 Mn |
| 9 | Pfizer | 173.68 Bn | 120.32 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Vertex Pharmaceuticals | 141.76 Bn | 113.76 Bn | 2.84 Bn | 112.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 321.00 Mn |
| Mar 31, 2026 | -346.00 Mn |
| Dec 31, 2025 | -609.00 Mn |
| Sep 30, 2025 | -354.00 Mn |
| Jun 30, 2025 | 331.00 Mn |
| Mar 31, 2025 | -254.00 Mn |
| Dec 31, 2024 | -558.00 Mn |
| Sep 30, 2024 | -321.00 Mn |
| Jun 30, 2024 | 260.00 Mn |
| Mar 31, 2024 | -227.00 Mn |
| Dec 31, 2023 | -406.00 Mn |
| Sep 30, 2023 | -261.00 Mn |
| Jun 30, 2023 | 225.00 Mn |
| Mar 31, 2023 | -168.00 Mn |
| Dec 31, 2022 | -306.00 Mn |
| Sep 30, 2022 | -221.00 Mn |
| Jun 30, 2022 | 257.00 Mn |
| Mar 31, 2022 | -257.00 Mn |
| Dec 31, 2021 | -460.00 Mn |
| Sep 30, 2021 | -351.00 Mn |
API Access
Novartis Ag Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();